Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial

Simke W Waijer; Sieta T de Vries; Robert Busch; Di Xie; Ron T Gansevoort; Fan Fan Hou; Jose L Górriz; Gozewijn D Laverman; Luca De Nicola; Julio Pascual; Michele Provenzano; Pablo E Pergola; Sydney C W Tang; Christoph Wanner; Philippe Zaoui; Hans-Henrik Parving; Dick de Zeeuw; Hiddo J L Heerspink

doi:10.1681/ASN.2021040498

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial

Simke W Waijer, Sieta T de Vries, Robert Busch, Di Xie, Ron T Gansevoort, Fan Fan Hou, Jose L Górriz, Gozewijn D Laverman, Luca De Nicola, Julio Pascual, Michele Provenzano, Pablo E Pergola, Sydney C W Tang, Christoph Wanner, Philippe Zaoui, Hans-Henrik Parving, Dick de Zeeuw, Hiddo J L Heerspink

Originalsprog	Engelsk
Tidsskrift	Journal of the American Society of Nephrology
Vol/bind	32
Udgave nummer	11
Sider (fra-til)	2731-2734
Antal sider	4
ISSN	1046-6673
DOI	https://doi.org/10.1681/ASN.2021040498
Status	Udgivet - nov. 2021

Adgang til dokumentet

10.1681/ASN.2021040498

Andre filer og links

Link to publication in Scopus

Citationsformater

Waijer, S. W., de Vries, S. T., Busch, R., Xie, D., Gansevoort, R. T., Hou, F. F., Górriz, J. L., Laverman, G. D., De Nicola, L., Pascual, J., Provenzano, M., Pergola, P. E., Tang, S. C. W., Wanner, C., Zaoui, P., Parving, H.-H., de Zeeuw, D., & Heerspink, H. J. L. (2021). Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial. Journal of the American Society of Nephrology, 32(11), 2731-2734. https://doi.org/10.1681/ASN.2021040498

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial. / Waijer, Simke W; de Vries, Sieta T; Busch, Robert et al.
I: Journal of the American Society of Nephrology, Bind 32, Nr. 11, 11.2021, s. 2731-2734.

Publikation: Bidrag til tidsskrift › Letter › peer review

Waijer, SW, de Vries, ST, Busch, R, Xie, D, Gansevoort, RT, Hou, FF, Górriz, JL, Laverman, GD, De Nicola, L, Pascual, J, Provenzano, M, Pergola, PE, Tang, SCW, Wanner, C, Zaoui, P, Parving, H-H, de Zeeuw, D & Heerspink, HJL 2021, 'Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial', Journal of the American Society of Nephrology, bind 32, nr. 11, s. 2731-2734. https://doi.org/10.1681/ASN.2021040498

@article{73a48ce4e3ba42d89892d5368708900b,

title = "Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial",

keywords = "Atrasentan/therapeutic use, Biological Variation, Individual, Endothelin A Receptor Antagonists/therapeutic use, Glomerular Filtration Rate, Humans, chronic kidney disease, type 2 diabetes, endothelin receptor antagonist, eGFR decline, randomized controlled trials",

author = "Waijer, {Simke W} and {de Vries}, {Sieta T} and Robert Busch and Di Xie and Gansevoort, {Ron T} and Hou, {Fan Fan} and G{\'o}rriz, {Jose L} and Laverman, {Gozewijn D} and {De Nicola}, Luca and Julio Pascual and Michele Provenzano and Pergola, {Pablo E} and Tang, {Sydney C W} and Christoph Wanner and Philippe Zaoui and Hans-Henrik Parving and {de Zeeuw}, Dick and Heerspink, {Hiddo J L}",

year = "2021",

month = nov,

doi = "10.1681/ASN.2021040498",

language = "English",

volume = "32",

pages = "2731--2734",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "The American Society of Nephrology",

number = "11",

}

TY - JOUR

T1 - Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy

T2 - A Post Hoc Analysis from the SONAR Trial

AU - Waijer, Simke W

AU - de Vries, Sieta T

AU - Busch, Robert

AU - Xie, Di

AU - Gansevoort, Ron T

AU - Hou, Fan Fan

AU - Górriz, Jose L

AU - Laverman, Gozewijn D

AU - De Nicola, Luca

AU - Pascual, Julio

AU - Provenzano, Michele

AU - Pergola, Pablo E

AU - Tang, Sydney C W

AU - Wanner, Christoph

AU - Zaoui, Philippe

AU - Parving, Hans-Henrik

AU - de Zeeuw, Dick

AU - Heerspink, Hiddo J L

PY - 2021/11

Y1 - 2021/11

KW - Atrasentan/therapeutic use

KW - Biological Variation, Individual

KW - Endothelin A Receptor Antagonists/therapeutic use

KW - Glomerular Filtration Rate

KW - Humans

KW - chronic kidney disease

KW - type 2 diabetes

KW - endothelin receptor antagonist

KW - eGFR decline

KW - randomized controlled trials

UR - http://www.scopus.com/inward/record.url?scp=85119041825&partnerID=8YFLogxK

U2 - 10.1681/ASN.2021040498

DO - 10.1681/ASN.2021040498

M3 - Letter

C2 - 34417318

SN - 1046-6673

VL - 32

SP - 2731

EP - 2734

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 11

ER -